NEURODERM LTD's ticker is and the CUSIP is M74231107. A total of 85 filers reported holding NEURODERM LTD in Q3 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,331,000 | -91.5% | 44,516 | -92.5% | 0.17% | -91.6% |
| Q1 2017 | $15,665,000 | -33.2% | 590,000 | -44.1% | 2.00% | -57.8% |
| Q4 2016 | $23,450,000 | +84.8% | 1,056,303 | +53.9% | 4.74% | +112.7% |
| Q3 2016 | $12,690,000 | +40.2% | 686,303 | +23.2% | 2.23% | +10.7% |
| Q2 2016 | $9,051,000 | +19.3% | 557,003 | +3.6% | 2.01% | -24.0% |
| Q1 2016 | $7,589,000 | -14.4% | 537,477 | +3.4% | 2.65% | -13.3% |
| Q4 2015 | $8,866,000 | -61.1% | 520,022 | -52.9% | 3.05% | -48.5% |
| Q3 2015 | $22,801,000 | +300.2% | 1,103,093 | +197.2% | 5.93% | +277.8% |
| Q2 2015 | $5,697,000 | – | 371,111 | – | 1.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 327,240 | $9,784,000 | 4.26% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,383,358 | $131,062,000 | 2.70% |
| SENZAR ASSET MANAGEMENT, LLC | 357,400 | $10,686,000 | 2.63% |
| Rhenman & Partners Asset Management AB | 461,654 | $13,803,000 | 1.98% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 168,025 | $5,007,000 | 1.90% |
| GREAT POINT PARTNERS LLC | 311,000 | $9,299,000 | 1.67% |
| Opaleye Management Inc. | 120,300 | $3,597,000 | 1.50% |
| SECTORAL ASSET MANAGEMENT INC | 350,085 | $10,468,000 | 1.14% |
| MENORA MIVTACHIM HOLDINGS LTD. | 808,073 | $24,161,000 | 1.13% |
| Redmile Group, LLC | 555,096 | $16,597,000 | 1.01% |